# Sources — Joe Frazier

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

Accessed November 4, 2026. The canonical source metadata and claim links are in `case.json`.

## Historical evidence

1. Sielski M. Joe Frazier biography, ESPN Classic (written during his life; it describes events through 2001). Supports his birth on January 12, 1944, in Beaufort County, South Carolina, the eleventh child of a sharecropper; his move to Philadelphia as a teenager and his work in a slaughterhouse; the 1964 Olympic gold medal won with a broken left thumb; that later in 1964 he learned he had cataracts in his left eye and, though visually impaired, turned professional; the cataract growing worse before the 1975 bout; the heavyweight title from February 16, 1970 to January 22, 1973; his record of 32-4-1 with 27 knockouts, retirement in 1976 and one bout five years later; his 1996 autobiography *Smokin' Joe*; that he lived in Philadelphia and owned and ran a gym there; and that “he has diabetes and high blood pressure.” http://www.espn.com/classic/biography/s/frazier_joe.html
2. Diskin B. “Smokin' Joe had vicious left hook,” ESPN Classic, November 19, 2003. Supports that in 1975, according to his eye doctor, his vision was 20/50 in the right eye and, because of the cataracts, 20/400 in the left. http://www.espn.com/classic/s/Frazier_joe_add.html
3. ESPN.com news services. “Boxing legend Joe Frazier dies,” November 7, 2011. Obituary: born in Beaufort, South Carolina, on January 12, 1944; the 1964 gold medal; the title won in 1970; running a gym in Philadelphia in later years; death after a brief battle with liver cancer at 67. https://www.espn.com/boxing/story/_/id/7206261
4. Gelston D, Dahlberg T (Associated Press). “Philadelphia boxing legend Joe Frazier dies,” *The Philadelphia Inquirer*, November 7, 2011. Obituary: birth date and place; the 1964 gold medal with an injured left thumb; the 1970 title; that in the 1975 bout he “simply couldn't see” and his trainer would not let him continue; later financial trouble and running a gym in Philadelphia. https://www.inquirer.com/philly/sports/boxing/Philadelphia_boxing_legend_Joe_Frazier_dies.html
5. Associated Press. “Joe Frazier dead at 67,” CBS Los Angeles, November 7, 2011. Supports, from his personal and business manager, that he was diagnosed with liver cancer the month before his death, was in and out of the hospital from early October, and received hospice care in his last week; from a family friend, home hospice care after a diagnosis weeks earlier; the family's release confirming his death; and four successful title defenses. https://www.cbsnews.com/losangeles/news/joe-frazier-dead-at-67
6. Associated Press. “Ex-champ Frazier dies of liver cancer,” *The Vindicator*, November 8, 2011. Supports home hospice care. https://vindyarchives.com/news/2011/nov/08/ex-champ-frazier-dies-of-liver-cancer
7. *The Irish Times*. “Cancer catches Joe Frazier,” November 8, 2011. Supports hospice care after a diagnosis “just over a month ago,” his birth in Beaufort, South Carolina, and the Tokyo gold medal. https://www.irishtimes.com/news/cancer-catches-joe-frazier-1.1285648
8. HISTMED Master Roster v3. Internal project source; not treated as independent corroboration.

## Clinical guidance

1. American Diabetes Association. Standards of Care in Diabetes-2026, *Diabetes Care* 2026;49(Suppl 1): section 1, populations (PMID 41358887); section 4, comprehensive evaluation and comorbidities, including MASLD screening with FIB-4 (PMID 41358897); section 9, pharmacologic approaches (PMID 41358900); section 10, cardiovascular disease and risk management (PMID 41358899); section 11, chronic kidney disease (PMID 41358881); section 12, retinopathy, neuropathy and foot care (PMID 41358886). https://pubmed.ncbi.nlm.nih.gov/41358900/
2. 2025 AHA/ACC/AANP/AAPA/ABC/ACCP/ACPM/AGS/AMA/ASPC/NMA/PCNA/SGIM Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults. *J Am Coll Cardiol* 2025 (PMID 40815242). https://pubmed.ncbi.nlm.nih.gov/40815242/
3. Rinella ME, et al. AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease. *Hepatology* 2023;77(5) (PMID 36727674); the condition has since been renamed metabolic dysfunction-associated steatotic liver disease (MASLD). Used for FIB-4 followed by transient elastography and for the management of advanced fibrosis and cirrhosis. https://pubmed.ncbi.nlm.nih.gov/36727674/
4. Singal AG, et al. AASLD Practice Guidance on prevention, diagnosis, and treatment of hepatocellular carcinoma. *Hepatology* 2023;78(6) (PMID 37199193): surveillance with ultrasound, with or without AFP, every six months in cirrhosis. https://pubmed.ncbi.nlm.nih.gov/37199193/
5. de Franchis R, et al. Baveno VII - Renewing consensus in portal hypertension. *J Hepatol* 2022 (PMID 35120736): elastography and platelet rules for clinically significant portal hypertension and variceal screening. https://pubmed.ncbi.nlm.nih.gov/35120736/
6. Katz DI, et al. National Institute of Neurological Disorders and Stroke Consensus Diagnostic Criteria for Traumatic Encephalopathy Syndrome. *Neurology* 2021 (PMID 33722990): chronic traumatic encephalopathy is a neuropathological diagnosis. https://pubmed.ncbi.nlm.nih.gov/33722990/
7. CMID: Clinical Monitoring Intelligence Database (Aether Forge, 2026), diabetes type 2, hypertension and hyperlipidemia monographs. https://patrickrutledge.github.io/topthirty/
8. Centers for Disease Control and Prevention. Adult Immunization Schedule by Medical Condition and Other Indication. https://www.cdc.gov/vaccines/hcp/imz-schedules/adult-medical-condition.html
9. U.S. Preventive Services Task Force: A and B recommendations, colorectal cancer (2021), prostate cancer (2018), and depression (2023). https://www.uspreventiveservicestaskforce.org/uspstf/recommendation-topics/uspstf-a-and-b-recommendations
10. Medicare Preventive Services reference (Aether Forge, 2026). https://patrickrutledge.github.io/preventative_services/

## Editorial resolutions

- **Recent-death rule.** Frazier died in 2011, so the rule applies. The case uses only what was reported publicly during his life (two ESPN Classic pieces) and in obituaries and the public statements of his manager, a family friend and his family (ESPN, the Associated Press as carried by *The Philadelphia Inquirer*, CBS Los Angeles and *The Vindicator*, and *The Irish Times*). No sick visit is added. No claim concerns mental health or substance use; the modern PHQ screens are synthetic and below the threshold for a safety assessment. His death is recorded once (CLM-0010) in one plain sentence; the liver cancer is recorded once (CLM-0009) as history and does not appear in the modern episode.
- **Diabetes and hypertension.** Both were reported publicly during his life (ESPN Classic, CLM-0008), so the modern diabetes and hypertension are linked to a documented claim. Their duration (about twelve years), severity, treatment and every value are synthetic.
- **Liver disease is synthetic.** No source read reports fatty liver disease, fibrosis or cirrhosis in his life, or any cause for the liver cancer. The modern MASLD with compensated cirrhosis is a synthetic choice made to teach FIB-4, elastography and six-monthly surveillance that can find liver cancer early. The case does not suggest that this was the cause of his cancer, and his alcohol use was not researched and is not used.
- **The left eye.** The cataract found in 1964, his visual impairment when he turned professional and the 1975 vision figures were reported during his life (CLM-0004). Accounts that he hid the eye from examiners by memorizing the chart or switching hands appear in a magazine profile published after his death and in fan and forum sites; they are outside the rule and are not used. Accounts of a training injury and later surgery come from similar sources and are not used. The modern left-eye acuity is synthetic.
- **Brain health.** The roster lists occupational traumatic brain injury; no source read reports a brain injury or cognitive problem in his life. The modern episode records only the documented career (CLM-0005, CLM-0006), his synthetic question about memory, and a synthetic normal MoCA. No chronic traumatic encephalopathy or traumatic encephalopathy syndrome diagnosis is made.
- **Roster leads not used.** The rivalry's “bitterness” and its psychological burden are not recorded, because they would be mental health claims beyond the public medical record. Financial trouble is recorded only as reported in the AP obituary (CLM-0007).
- **Real people.** His rival, who has a record in this dataset, is not named, nor are other opponents. His trainer and manager appear only as sources of the public statements, unnamed in claims. No relative is named and nothing is attributed to any relative; the family's release is cited only for the fact of his death.
- **Alias.** “Smokin' Joe,” his nickname and the title of his 1996 autobiography (CLM-0011), appears in no other record. The apostrophe is a plain ASCII apostrophe; the build and the cross-case check handle it.
- **Index age and dates.** The index visit on February 16, 2026 maps to February 16, 2008, when he was 64, three and a half years before the liver cancer diagnosis in October 2011. The synthetic date of birth is January 12, 1962 (shift 18 years). The chronic-care visits on March 2, April 13, May 18 and September 14, 2026, the endoscopy on April 6, the eye examination on June 22 and the preventive visit on July 13, 2026 map to the same days of 2008. He lived and ran his gym in Philadelphia in those years; the episode does not contradict it. Past medical history includes only events up to the early 2000s.
- **Synthetic clinical picture.** Every value is synthetic: the A1c, kidney tests, urine albumin, lipids, liver tests, FIB-4 (3.43 and 3.12), liver stiffness (17.6 kPa), controlled attenuation parameter, AFP, INR, MoCA, PHQ scores, the ECG, foot, eye, ultrasound and endoscopy findings, the PSA (narrative only), the medicines and the outcomes. Height (182 cm) and weights are synthetic. Hepatitis, HIV, iron and autoimmune test results are narrative.
- **Clinical judgment calls.** (1) Compensated cirrhosis was diagnosed from a FIB-4 above 2.67, a stiffness of 17.6 kPa, platelets of 138 and ultrasound findings, without biopsy. (2) Endoscopy rather than a beta-blocker, because a stiffness of 15 to 25 kPa with platelets below 150 cannot rule portal hypertension in or out under Baveno VII; no varices were found. (3) Semaglutide was chosen for cardiovascular and kidney benefit, weight and steatotic liver disease; metformin and atorvastatin continued. (4) Amlodipine was added to lisinopril. (5) Aspirin was not used for primary prevention because of bleeding risk with cirrhosis. (6) RSV vaccine at 64 because of diabetes and chronic liver disease. (7) The preventive visit is a periodic adult preventive visit (CPT 99396 with 99497 in plain text), since he is under 65.
- **Preventive visit.** Colonoscopy ordered (last more than ten years earlier); PSA after shared decision-making, with his higher risk as a Black man discussed; MoCA 26; no lung or aortic screening (never smoked); zoster vaccine dose 1; advance care planning records an unnamed agent.
- **Focused visits.** The four chronic-care follow-ups (two weeks with the consultation, eight weeks, three months and seven months) are documented as focused visits on the CMID diabetes, hypertension and hyperlipidemia monographs with the ADA Standards of Care 2026 and the 2025 AHA/ACC guideline, and on the AASLD 2023 MASLD and HCC guidance and Baveno VII. One deviation is recorded instead of an invented result: the dilated eye examination planned at intake had not been done by three months because he missed the appointment and it was not rebooked; it mattered because A1c was falling quickly on semaglutide; no harm is known (no new symptoms, and the examination in June found no retinopathy); the clinic rebooked it on a day he chose with a reminder call. Synthetic findings introduced: no varices on endoscopy and a clear six-month surveillance ultrasound.
- **Consultation.** The hepatology referral and the consultation by Anjali Deshpande, MD (a fictional consultant), on the day of the two-week visit, are **S**. The consultant answers the five referral questions in line with what the record shows afterwards: MASLD with compensated cirrhosis, Child-Pugh A; ultrasound with AFP every six months, done in March and September; endoscopy within six weeks (no varices, repeat in two years); semaglutide with metformin and atorvastatin continued; hepatitis A and B, PCV20 and seasonal vaccines; no alcohol, no NSAIDs, acetaminophen limited; and repeat elastography at one year.
